Placental 11B-Hydroxysteroid Dehydrogenase Type 2 mRNA Levels in Intrauterine Growth Restriction versus Small-for-Gestational-Age Fetuses

Fetal Diagnosis and Therapy

Volumn 39, Issue 2, 2016, Pages 147-151

  Gómez Roig, M Dolores ^a,e   Mazarico, Edurne ^a,e   Cárdenas, Daniela ^a   Fernandez, M Teresa ^a   DÍaz, Marta ^b   Ruiz De Gauna, Beatriz ^a   Vela, Antonio ^a,e   Gratacós, Eduard ^a,c,d   Figueras, Francesc ^a,c,d  

^a Fetal I+D Fetal Medicine Research Center   (Spain)

^b Paediatric Rheumatology Unit   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

11B hydroxysteroid dehydrogenase; Intrauterine growth restriction; Placental gene expression; Small for gestational age

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; HYDROCORTISONE; MESSENGER RNA; 11BETA HYDROXYSTEROID DEHYDROGENASE;

ADULT; ARTICLE; BIRTH WEIGHT; CLINICAL ARTICLE; FEMALE; FETUS; GESTATIONAL AGE; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL SMOKING; NEWBORN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; RNA EXTRACTION; SMALL FOR DATE INFANT; DIAGNOSTIC IMAGING; FETUS ECHOGRAPHY; GENETICS; METABOLISM; PLACENTA; PREGNANCY; UTERINE ARTERY;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; BIRTH WEIGHT; FEMALE; FETAL GROWTH RETARDATION; HUMANS; INFANT, NEWBORN; INFANT, SMALL FOR GESTATIONAL AGE; PLACENTA; PREGNANCY; RNA, MESSENGER; ULTRASONOGRAPHY, PRENATAL; UTERINE ARTERY;

EID: 84939481065     PISSN: 10153837     EISSN: 14219964     Source Type: Journal    
DOI: 10.1159/000437139     Document Type: Article

References (28)

1. Oros D, Figueras F, Cruz-Martinez R, Meler E, Munmany M, Gratacos E: Longitudinal changes in uterine, umbilical and fetal cerebral Doppler indices in late-onset small-forgestational age fetuses. Ultrasound Obstet Gynecol 2011; 37: 191-195.
2. Figueras F, Gratacós E: Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther 2014; 36: 86-98.
3. Krozowski Z: The 11B-hydroxysteroid dehydrogenases: functions and physiological effects. Mol Cell Endocrinol 1999; 151: 121-127.
4. McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, Kilby MD, Stewart PM: Reduced placental 11B-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. Clin Endocrinol Metab 2001; 86: 4979-4983.
5. Shams M, Kilby MD, Somerset DA, Howie AJ, Gupta A, Wood PJ, Afnan M, Stewart PM: 11B-hydroxysteroid dehydrogenase type 2 in human pregnancy and reduced expression in intrauterine growth restriction. Hum Reprod 1998; 13: 799-804.
6. Seckl JR: Glucocorticoid programming of the fetus, adult phenotypes and molecular mechanisms. Mol Cell Endocrinol 2001; 185: 61-71.
7. Stewart PM, Rogerson FM, Mason JI: Type 2 11B-hydroxysteroid dehydrogenase messenger ribonucleic acid and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal adrenal steroidogenesis. J Clin Endocrinol Metab 1995; 80: 885-890.
8. Marsit CJ, Maccani MA, Padbury JF, Lester BM: Placental 11B-hydroxysteroid dehydrogenase methylation is associated with newborn growth and a measure of neurobehavioral outcome. PLoS One 2012; 7:e33794.
9. McTernan CL, Draper N, Nicholson H, Chalder SM, Driver P, Hewison M, Kilby MD, Stewart PM: Reduced placental 11B-hydroxysteroid dehydrogenase type 2 mRNA levels in human pregnancies complicated by intrauterine growth restriction: an analysis of possible mechanisms. Clin Endocrinol Metab 2001; 86: 4979-4983.
10. Figueras F, Meler E, Iraola A, Eixarch E, Coll O: Customized birthweight standards for a Spanish population. Eur J Obstet Gynecol Reprod Biol 2008; 136: 20-24.
11. Arduini D, Rizzo G: Normal values of pulsatility index from fetal vessels: a cross-sectional study on 1556 healthy fetuses. J Perinat Med 1990; 18: 165-172.
12. Baschat AA, Gembruch U: The cerebroplacental Doppler ratio revisited. Ultrasound Obstet Gynecol 2003; 21: 124-127.
13. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001; 20:IX-XIV.
14. Robinson HP, Fleming JE: A critical evaluation of sonar 'crown-rump length' measurements. Br J Obstet Gynaecol 1975; 82: 702-710.
15. Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK: Estimation of fetal weight with the use of head, body, and femur measurements-a prospective study. Am J Obstet Gynecol 1985; 151: 333-337.
16. Mari G, Moise KJ, Deter RL, Kirshon B, Carpenter RJ, Huhta J: Doppler assessment of the pulsatility index in the cerebral circulation of the human fetus. Am J Obstet Gynecol 1989; 160: 698-703.
17. Gramellini D, Folli MC, Raboni S, Vadora E, Merialdi A: Cerebral-umbilical Doppler ratio as a predictor of adverse perinatal outcome. Obstet Gynecol 1992; 74: 416-420.
18. Parra-Saavedra M, Simeone S, Triunfo S, Crovetto F, Botet F, Nadal A, Gratacos E, Figueras F: Correlation between placental underperfusion, histologic signs and perinatal morbidity in late-onset small for gestational age fetuses. Ultrasound Obstet Gynecol 2015; 45: 149-155.
19. Aviram R, T BS, Kidron D: Placental aetiologies of foetal growth restriction: clinical and pathological differences. Early Hum Dev 2010; 86: 59-63.
20. Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, von Dadelszen P: Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol 2012; 206: 163.
21. Savchev S, Figueras F, Cruz-Martinez R, Illa M, Botet F, Gratacos E: Estimated weight centile as a predictor of perinatal outcome in small-for-gestational-age pregnancies with normal fetal and maternal Doppler indices. Ultrasound Obstet Gynecol 2012; 39: 299-303.
22. Korgun ET, Ozmen A, Unek G, Mendilcioglu I: The effects of glucocorticoids on fetal and placental development; in Qian X (ed): Glucocorticoids-New Recognition of Our Familiar Friend. Rijeka, Intech Open Science, 2012, chapt 13.
23. Börzsönyi B, Demendi C, Pajor A, Rigó J Jr, Marosi K, Agota A, Nagy ZB, Joó JG: Gene expression patterns of the 11?-hydroxysteroid dehydrogenase 2 enzyme in human placenta from intrauterine growth restriction: the role of impaired feto-maternal glucocorticoid metabolism. Eur J Obstet Gynecol Reprod Biol 2012; 161: 12-17.
24. Kanaka C: Endocrine-related causes and consequences of intrauterine growth retardation. Ann NY Acad Sci 2006; 997: 150-157.
25. Barker DJ: Adult consequences of fetal growth restriction. Clin Obstet Gynecol 2006; 49: 270-283.
26. Parra-Saavedra M, Crovetto F, Triunfo S, Savchev S, Peguero A, Nadal A, Gratacós E, Figueras F: Association of Doppler parameters with placental signs of underperfusion in late-onset small-for-gestational-age pregnancies. Ultrasound Obstet Gynecol 2014; 44: 330-337.
27. Parra-Saavedra M, Crovetto F, Triunfo S, Savchev S, Peguero A, Nadal A, Parra G, Gratacos E, Figueras F: Neurodevelopmental outcomes of near-term small-for-gestationalage infants with and without signs of placental underperfusion. Placenta 2014; 35: 269-274.
28. Triunfo S, Lobmaier S, Parra-Saavedra M, Crovetto F, Peguero A, Nadal A, Gratacos E, Figueras F: Angiogenic factors at diagnosis of late-onset small-for-gestational age and histological placental underperfusion. Placenta 2014; 35: 398-403.